NCT02735239 Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02730546 Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery Status COMPLETED Phase PHASE1/PHASE2
NCT02725424 Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer Status COMPLETED Phase PHASE2
NCT02720926 Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer Status TERMINATED Phase PHASE1
NCT02720068 Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001) Status COMPLETED Phase PHASE1
NCT02716766 Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC) Status COMPLETED Phase PHASE2
NCT02715531 A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors Status COMPLETED Phase PHASE1
NCT02694718 A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer Status COMPLETED Phase PHASE2
NCT02692248 Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to ASCT Status COMPLETED Phase PHASE2
NCT02661971 FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES) Status COMPLETED Phase PHASE2/PHASE3
NCT02641691 Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum Status COMPLETED Phase PHASE2
NCT02635971 Intra-arterial Versus Intravenous Chemotherapy for Locally Advanced Pancreatic Cancer Status UNKNOWN Phase PHASE2
NCT02625610 Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) Status COMPLETED Phase PHASE3
NCT02623153 Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer Status UNKNOWN Phase PHASE2
NCT02620865 BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02620800 Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02605265 Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1 Status COMPLETED Phase PHASE3
NCT02585479 Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma Status WITHDRAWN Phase PHASE2/PHASE3